PBLA

Panbela Therapeutics, Inc. PBLA

PBLA
Panbela Therapeutics, Inc. EHOS
Ehouse Global, Inc. MOBO
Mobile Lads Corp. BRAXF
Braxia Scientific Corp. HTDS
Hard to Treat Diseases Inc. IRBS
IR Biosciences Holdings Inc. NVOS
Novo Integrated Sciences, Inc. BBBT
Black Bird Biotech, Inc. ADVT
Advantis Corp. OMHE
Omni Health, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PBLA EHOS MOBO BRAXF HTDS IRBS NVOS BBBT ADVT OMHE
6M -99.91 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 5.00 % 0.00 % 0.00 % 200.00 %
YTD -99.96 % 900.00 % 0.00 % -14.67 % 1 900.00 % 0.00 % -95.83 % 0.00 % 0.00 % 200.00 %
1Y -99.94 % 900.00 % -96.55 % -47.76 % 100.00 % 0.00 % -93.54 % 0.00 % 0.00 % 200.00 %
3Y -100.00 % -90.00 % -99.41 % -95.59 % 100.00 % 5 900.00 % -99.91 % -90.91 % -90.00 % -40.00 %
5Y -100.00 % 49 900.00 % -99.50 % -99.82 % 100.00 % 5 900.00 % -99.95 % -99.76 % -97.50 % -90.00 %
10Y -100.00 % 9 999 900.00 % -99.89 % -99.46 % -80.00 % 5 900.00 % -99.95 % -97.56 % -99.83 % -99.51 %
From the beginning -100.00 % -66.67 % -99.97 % -99.46 % -100.00 % 5 900.00 % -99.95 % -99.99 % -100.00 % 50.00 %

Dividend